aTyr Pharma, Inc. (ATYR) Financials

ATYR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 79.7 million 21.9 million
Dec. 31, 2025 94.2 million 26.9 million
Sept. 30, 2025 106.7 million 26.6 million
June 30, 2025 101.5 million 26.9 million

ATYR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -12.7 million 1.3 million
Dec. 31, 2025 -12.2 million 1.2 million
Sept. 30, 2025 -20.5 million 1.3 million
June 30, 2025 -13.9 million 1.3 million

ATYR Net Income

No data available :(

ATYR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 66.5 million - 10.2 million
Dec. 31, 2025 78.7 million - 10.6 million
Sept. 30, 2025 90.2 million - 10.9 million
June 30, 2025 80.3 million - 12.7 million

ATYR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 98.0 million
Dec. 31, 2025 98.0 million
Sept. 30, 2025 97.2 million
June 30, 2025 90.1 million

ATYR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 138000 7.3 million 4.1 million -
Dec. 31, 2025 31000 10.9 million 3.9 million -
Sept. 30, 2025 37000 22.1 million 4.8 million -
June 30, 2025 9000 15.4 million 4.9 million -

ATYR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 394000
Dec. 31, 2025 - 394000
Sept. 30, 2025 190000 22.1 million
June 30, 2025 - 387000

ATYR Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ATYR

Price: $0.45

52 week price:
0.40
7.29

Earnings Per Share: -0.74 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 50.3 million

Links: